Class ITerminatedD-0561-2022
Drug recall · February 16, 2022
HARD DAWN recall
Why: Marketed Without an Approved NDA/ANDA: Firm was informed by Amazon that analytical testing showed the presence of tadalafil. Tadalafil is a FDA approved drug, making this product an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
HARD DAWN, Rise and Shine capsules, 500 mg, packaged in 10-count blisters per carton, Made in Malaysia, UPC 680044 364926, ASIN: B077XCCL59
- Lots / codes
Lot: 2107, Exp July 2024
- Quantity
- 500 cartons
- Company
- Esupplementsales, LLC, Reno, NV
- Distribution
- Nationwide in the USA via Amazon at www.amazon.com
- Initiated
- January 28, 2022 · Voluntary: Firm initiated
- Classified
- February 15, 2022
- Reported
- February 16, 2022
- Ended
- August 17, 2022
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.